Jabrzyk, M. (2026) “The Role and Efficacy of Rifaximin in the Treatment of Irritable Bowel Syndrome - Based on current research in 2026”, Quality in Sport, 53, p. 70303. doi: 10.12775/QS.2026.53.70303.